Risk of breast recurrence in relation to BRCA1/2 mutation status following breast-conserving surgery and radiotherapy
Kirova, Y.M.; Stoppa Lyonnet, D.; Savignoni, A.; Sigal Zafrani, B.; Clough, K.B.; Barbier, N.; Fourquet, A.
EJC Suppls 2(3): 150-151
2004
DOI: 10.1016/s1359-6349(04)90932-9
Accession: 035673717
PDF emailed within 0-6 h: $19.90
Related References
Powell, S.N. 2006: 35 Risk of Breast Cancer Recurrence and Contralateral Breast Cancer in Relation to Brca1 and Brca2 Mutation Status Following Breast-Conserving Surgery and Radiotherapy Breast Diseases: A Year Book Quarterly 17(3): 223-225Kirova, Y.M.; Stoppa-Lyonnet, D.; Savignoni, A.; Sigal-Zafrani, B.; Fabre, N.; Fourquet, A. 2005: Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy European Journal of Cancer 41(15): 2304-2311
Kirova, Y.M.; Stoppalyonnet, D.; Savignoni, A.; Sigalzafrani, B.; Fabre, N.; Fourquet, A.; I C B, C.S.G. 2005: Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy European Journal of Cancer (1990) 41(15): 2304-2311
Nara, M.; Ishihara, S.; Kitano, A.; Tamura, N.; Aruga, T.; Kobayashi, D.; Nakamura, S.; Yamauchi, H. 2022: Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? a systematic review and meta-analysis Breast Cancer 29(3): 394-401
Savignoni, A.; Kirova, Y.M.; Fourquet, A.; Sigal-Zafr, B. 2006: Risk of Second Non Breast Malignancies (SNBM) in Relation to BRCA1 and BRCA2 Mutation Status Following Breast-Conserving Surgery and RadioTherapy American Journal of Immunology 2(3): 61-63
Cao, W.; Xie, Y.; He, Y.; Li, J.; Wang, T.; Fan, Z.; Fan, T.; Ouyang, T. 2019: Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China Breast Cancer Research and Treatment 175(3): 749-754
Ishitobi, M.; Nakahara, S.; Komoike, Y.; Motomura, K.; Koyama, H.; Inaji, H. 2011: Risk of Ipsilateral breast tumor recurrence in patients treated with Tamoxifen or Anastrozole following breast-conserving surgery with or without radiotherapy Anticancer Research 31(1): 367-371
Truong, P.; Lupe, K.; Alexander, C.; Lesperance, M.; Tyldesley, S. 2010: Subsets of Women with Close or Positive Margins after Breast Conserving Surgery with High Local Recurrence Risk Despite Breast Plus Boost RadioTherapy International Journal of Radiation Oncology*Biology*Physics 78(3): S52-S53
Lupe, K.; Truong, P.T.; Alexander, C.; Lesperance, M.; Speers, C.; Tyldesley, S. 2011: Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy International Journal of Radiation Oncology Biology Physics 81(4): E561-E568
Kirova, Y.; Savignoni; Stoppa-Lyonnet, D; Sigal-Zafrani, B; Fourquet, A. 2006: Risk of second non breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving treatment European Journal of Cancer Suppls 4(2): 127-128
Mo, C.; Ruan, W.; Lin, J.; Chen, H.; Chen, X. 2021: Repeat Breast-Conserving Surgery Versus Salvage Mastectomy for Ipsilateral Breast Tumour Recurrence After Breast-Conserving Surgery in Breast Cancer Patients: a Meta-Analysis Frontiers in Oncology 11: 734719
Pierce, L.; Levin, A.; Rebbeck, T.; Kardia, S.; Bendavid, M.; Harris, E.; Solin, L.; Haffty, B.; Wynen, E.; Gaffney, D.; Narod, S.; Metcalfe, K.; Dawson, L.; Eisen, A.; Whelan, T.; Olivotto, I.; Galinsky, D.; Meirovitz, A.; Olopade, O.; Garber, J.; Nixon, A.; Merajver, S.; Isaacs, C. 2003: Ten-year outcome of breast-conserving surgery and radiotherapy in women with breast cancer and germline BRCA 1/2 mutations Results from an international collaboration Breast Cancer Research and Treatment 82(Suppl 1): S7
Chen, K.; Jia, W.; Li, S.; He, J.; Zeng, Y.; Yang, H.; Jin, L.; Wu, X.; Su, F. 2011: Cavity margin status is an independent risk factor for local-regional recurrence in breast cancer patients treated with neoadjuvant chemotherapy before breast-conserving surgery American Surgeon 77(12): 1700-1706
Fourquet, A.; Dreyfus, H.; Colombani, H.; Maher, M.; Gozy, M.; Campana, F.; Vilcoq, J.R. 1995: Influence of surgery-radiotherapy interval on recurrence in breast-conserving treatment of small breast cancer International Journal of Radiation Oncology Biology Physics 32(Suppl 1): 260
Trimboli, R.M.; Schiaffino, S.; Sardanelli, F. 2019: In BRCA mutation carriers breast conserving surgery may not be the best choice Breast Cancer Research and Treatment 178(1): 245-246
Noh, J.M.; Lee, J.; Choi, D.H.; Cho, E.Y.; Huh, S.J.; Park, W.; Nam, S.J.; Lee, J.E.; Kil, W.-H. 2013: HER-2 overexpression is not associated with increased ipsilateral breast tumor recurrence in DCIS treated with breast-conserving surgery followed by radiotherapy Breast 22(5): 894-897
Vinh-Hung, V.; Verschraegen, C. 2004: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality Journal of the National Cancer Institute 96(2): 115-121
Ishitobi, M.; Komoike, Y.; Motomura, K.; Koyama, H.; Inaji, H. 2010: Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence Breast Journal 16(1): 9-13
Dong, Y.; Zhang, W.-W.; Wang, J.; Sun, J.-Y.; He, Z.-Y.; Wu, S.-G. 2019: The 21-gene recurrence score and effects of adjuvant radiotherapy after breast conserving surgery in early-stage breast cancer Future Oncology 15(14): 1629-1639
Vinh-Hung, V.; Verschraegen, C.; Royce, M.; Van de Steene, J.; Tai, P.; Cserni, G.; Storme, G.; Vlastos, G. 2004: Response: Re: Breast-Conserving Surgery With or Without Radiotherapy: Pooled-Analysis for Risks of Ipsilateral Breast Tumor Recurrence and Mortality Jnci Journal of the National Cancer Institute 96(16): 1255-1257